Dolutegravir-d5

Cat. No.: IBDI-434061

Dolutegravir-d5 is deuterium labeled Dolutegravir. Dolutegravir (S/GSK1349572) is a highly potent and orally bioavailable HIV integrase strand transfer inhibitor with an IC50 of 2.7 nM for HIV-1 integrase-catalyzed strand transfer. Dolutegravir (S/GSK1349572) inhibits HIV-1 viral replication with an IC50 of 0.51 nM in peripheral blood mononuclear cells. Dolutegravir retains a high potency against the HIV-1 Y143R, N155H, and G140S/Q148H mutants (EC50=3.6-5.8 nM).

Product Details

Target	HIV | IntegRase | HIV
Molecular Weight	424.41
Synonyms	S/GSK1349572-d5
SMILES	FC1=C([2H])C(F)=C(C([2H])=C1[2H])C([2H])([2H])NC(C2=CN(C3=C(C2=O)O)C[[email protected]@]([H])(N4C3=O)OCC[[email protected]]4C)=O

Storage & Handling

Shipping	Room temperature in continental US. May vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status	This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.